Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2025-12-25 @ 3:18 AM
NCT ID:
NCT06846905
Eligibility Criteria:
Inclusion Criteria:
* Relapsed and/or refractory multiple myeloma
* Treated with teclistamab, elranatamab ou talquetamab
* More than 18 years old
* Having received the information from the study and not having objected to participate
* Day hospital care in case of clinical feasibility (good general condition, no rapid progression or major tumor burden, no current infection) and logistics (accommodated less than 30 minutes from the IUCT Oncopole for 48 hours after each dose escalation) or in conventional hospitalization at the IUCT Oncopole
Exclusion Criteria:
* Illiterate subjects or those with a language barrier
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06846905
Study Brief:
Protocol Section:
NCT06846905